Primary Treatment of Malignant Pleural Effusions: Video-Assisted Thoracoscopic Surgery Poudrage versus Tube Thoracostomy

Erickson, Kurt V.; Yost, Michael; Bynoe, Raymond; Almond, Carl; Nottingham, James
November 2002
American Surgeon;Nov2002, Vol. 68 Issue 11, p955
Academic Journal
The objective of this study is to show that primary treatment of malignant pleural effusions secondary to ovarian carcinoma with video-assisted thoracoscopic surgery (VATS)-assisted talc poudrage (VATS-ATP) results in shorter hospital stays and reduced time with a chest tube than primary treatment with a chest tube and chemical pleurodesis. We conducted a retrospective chart review of all patients with a symptomatic pleural effusion secondary to primary ovarian carcinoma receiving intervention from January 1996 to December 2000. Patients either received tube thoracostomy with pleurodesis (n = 22) or VATS-ATP (n = 12). Of the patients treated with tube thoracostomy 18 per cent (4/21) died in the hospital before pleurodesis, 77 per cent (14/19) had successful pleurodesis, and 22 per cent (4/18) failed pleurodesis requiring VATS-ATP. In the group treated primarily with tube thoracostomy the chest tube was in place 8.36 ± 2.61 days with a hospital stay of 12.64 ± 5.80 days after the procedure. In the group treated with VATS-ATP there was 100 per cent successful pleurodesis. There were no mortalities. There was one prolonged intubation of 3 days and one incomplete lung reexpansion. The chest tube was in place for 4.58 ± 1.78 days and a hospital stay of 7.50 ± 4.12 days postprocedure. Groups treated by tube thoracostomy and VATS were statistically different; P < 0.001 for days with a chest tube and P = 0.011 for hospital days. We conclude that both tube thoracostomy with chemical pleurodesis and VATS-ATP provide adequate treatment of ovarian carcinoma-associated malignant pleural effusions. VATS-ATP provides a shorter duration of chest tube placement and postprocedure hospital stay.


Related Articles

  • Thoracoscopic Talc Poudrage Pleurodesis for Chronic Recurrent Pleural Effusions. Aetony, Yossef; King, Randel; Boutin, Christian // Annals of Internal Medicine;11/15/91, Vol. 115 Issue 10, p778 

    Presents a study which assessed the effectiveness of thoracoscopic talc poudrage for the treatment of chronic pleural effusions. Patients and methods; Results; Discussion; Conclusion.

  • Thoracoscopy versus thoracotomy: Indications and advantages. Weatherford, David A.; Stephenson, James E. // American Surgeon;Jan1995, Vol. 61 Issue 1, p83 

    Compares the perioperative courses of patients having undergone thoracoscopy to those having undergone thoracotomy. Operative indications for thoracoscopy; Success rate of thoracoscopy; Need for thoracotomy.

  • Endoscopic Transthoracic Sympathectomy with a Fine (2-mm) Thorascope in Palmar Hyperhidrosis: A Case Report. Okura, Toshihiko; Suzuki, Takashi; Suzuki, Shuichi; Kitami, Akihiko; Hori, Goichi // Journal of Laparoendoscopic & Advanced Surgical Techniques;Jun98, Vol. 8 Issue 3, p161 

    Presents a case of endoscopic transthoracic sympathectomy using a fine thoracoscope in palmar hyperhidrosis. Medical history of the patient; Comparison of preoperative with postoperative thermography; Reason the fine thorascope is unlikely to interfere with the manipulation of instruments.

  • Chapter 85: THORACOSCOPY.  // Understanding Surgery;2001, p337 

    This article discusses the procedure for a thoracoscopy. The patient is asleep during the procedure and one lung has to be selectively intubated. The scope is placed in a lower chest position and two or three small openings are made in other positions in the chest through which operating...

  • Balloon-Assisted Single-Port Thoracoscopic Debritment in Children with Thoracic Empyema. Tander, Burak; Ustun, Levent; Ariturk, Ender; Rizalar, Riza; Ayyildiz, Suat H.; Bernay, Ferit // Journal of Laparoendoscopic & Advanced Surgical Techniques;Aug2007, Vol. 17 Issue 4, p504 

    Purpose: In this study, we evaluated the results of a balloon-aided single-port thoracoscopic debritment of late-stage thoracic empyema in children. Patients and Methods: We retrospectively reviewed age, gender, duration of prehospital illness, physical findings, surgical interventions, and the...

  • Thoracoscopic Lobectomy for Severe Bronchiectasis in Children. Rothenberg, Steven S.; Kuenzler, Keith A.; Middlesworth, William // Journal of Laparoendoscopic & Advanced Surgical Techniques;Aug2009, Vol. 19 Issue 4, p555 

    Background/Purpose: Lung resection should be considered for severe, localized bronchiectasis causing recurrent infections in patients with cystic fibrosis (CF) and other diseases. This series represents our experience and results with thoracoscopic lobectomy for the treatment of severe...

  • The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions. Habal, Petr; Jankovicova, Karolina; Omran, Nedal; Kondelkova, Katerina; Krejsek, Jan; Mandak, Jiri // Biomedical Papers of the Medical Faculty of Palacky University i;Dec2013, Vol. 157 Issue 4, p311 

    Background. Malignant pleural effusions accumulate in the space between the visceral (inner) layer covering the lungs and the parietal (outer) layer covering the chest wall. Larger effusions compress the pulmonary parenchyma resulting in increasing dyspnoea. Treatment is always local and...

  • Educational Lecture 17.  // Annals of Oncology;2016 Supplement, Vol. 27, pvii69 

    No abstract available.

  • Bortezomib (Intrapleural): Myelomatous Pleural Effusion. Generali, Joyce; Cada, Dennis J. // Hospital Pharmacy;Jul2008, Vol. 43 Issue 7, p562 

    An excerpt from the quarterly publication "Off-Label DrugFacts" about the use of bortezomib in the treatment of myelomatous pleural effusion is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics